Psilocybin research is no longer just for hard-to-treat cases — a new trial targeted recurrent depression in people who had not failed standard treatment, and the results are promising – Space Daily

1. Psilocybin research is no longer just for hard-to-treat cases — a new trial targeted recurrent depression in people who had not failed standard treatment, and the results are promising  Space Daily
2. A Single Dose Of Psilocybin Can Lead To ‘Rapid’…

Continue Reading

News Source: news.google.com